W.W. Grainger Inc. Stock Rises Monday, Outperforms Market

Ocugen Inc

Change company Symbol lookup

Select an option...

OCGN Ocugen Inc

NEGG Newegg Commerce Inc

PHX PHX Minerals Inc

IRT Independence Realty Trust Inc

RLAY Relay Therapeutics Inc

CVU CPI Aerostructures Inc

MA Mastercard Inc

WDBG Neuro-Hitech Inc

GLRY Inspire Faithward Mid Cap Momentum ETF

WCC Wesco International Inc

Health Care : Biotechnology | Small Cap Growth

Company profile

Ocugen, Inc. is a biopharmaceutical company focused on developing gene therapies to cure blindness diseases and developing vaccine for COVID-19. The Company's technology pipeline includes: COVID-19 Vaccine (0.5), Modifier Gene Therapy Platform and Novel Biologic Therapies for Retinal Diseases. COVID-19 Vaccine candidate is focused on developing, manufacturing and commercializing COVAXIN for the prevention of COVID-19 in humans in the Ocugen Covaxin Territory. COVAXIN is a whole-virion inactivated COVID-19 vaccine candidate and is formulated with the inactivated SARS-CoV-2 virus. The Modifier Gene Therapy platform is designed for retinal diseases, including retinitis pigmentosa (RP), leber congenital amaurosis (LCA) and dry age-related macular degeneration (AMD). It is developing OCU200, a biologic product candidate to treat diabetic macular edema (DME), diabetic retinopathy (DR) and wet AMD. OCU400, its first product candidate being developed with its modifier gene therapy platform.

W.W. Grainger Inc. Stock Rises Monday, Outperforms Market

4:58 pm ET December 19, 2022 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of W.W. Grainger Inc. (GWW) inched 0.47% higher to $561.27 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.90% to 3,817.66 and Dow Jones Industrial Average falling 0.49% to 32,757.54. The stock's rise snapped a four-day losing streak. W.W. Grainger Inc. closed $50.79 short of its 52-week high ($612.06), which the company achieved on November 10th.

The stock outperformed some of its competitors Monday, as Amazon.com Inc. (AMZN) fell 3.35% to $84.92, Home Depot Inc. (HD) fell 1.86% to $317.33, and Lowe's Cos. (LOW) fell 1.44% to $203.17. Trading volume (287,861) remained 30,673 below its 50-day average volume of 318,534.

Data source: Dow Jones Market Data, FactSet. Data compiled December 19, 2022.

(END) Dow Jones Newswires

December 19, 2022 16:58 ET (21:58 GMT)